Medicine for treating dermatitis and preparation method thereof

A drug and dermatitis technology, applied in the field of medicine, can solve problems such as inability to use long-term treatment, reduce immune defense, etc., and achieve the effect of stopping allergic reactions, reducing the rate of allergies, and coordinating healing

Inactive Publication Date: 2017-03-22
林维星
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] At present, the external medicines for dermatitis are mostly dermatitis hormones, supplemented by antibiotics, oral antihistamines combined with topical steroid h

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0029] A preparation method of a medicine for treating dermatitis, comprising the following steps:

[0030] 1) Weigh the oil phase components and heat to 80°C, stir for 20 minutes to obtain the oil phase mixture;

[0031] The oil phase component includes the following raw materials in parts by weight: 4 parts of glyceryl monostearate, 4 parts of PEG-100 stearate, 2 parts of stearic acid, 0.5 part of glycyrrhetinic acid, 1 part of lanolin, 2 parts of part shea butter;

[0032] Weigh the water phase components and heat to 80°C, stir for 20 minutes to obtain the water phase mixture; the water phase components include the following raw materials in parts by weight: 3 parts of glycerin, 0.8 parts of diphenhydramine hydrochloride, 55 parts of purified water;

[0033] Weigh the active pharmaceutical component and heat it to 50°C, stir for 20min to obtain the aqueous phase mixture; the active pharmaceutical mixture; the active pharmaceutical component includes the following raw mater...

Embodiment 2

[0037] A preparation method of a medicine for treating dermatitis, comprising the following steps:

[0038] 1) Weigh the oil phase components and heat to 80°C, stir for 25 minutes to obtain the oil phase mixture;

[0039] The oil phase component includes the following raw materials in parts by weight: 5 parts of glyceryl monostearate, 4 parts of PEG-100 stearate, 2 parts of stearic acid, 1 part of glycyrrhetinic acid, 1 part of lanolin, 2 parts of part shea butter;

[0040] Weigh the water phase components and heat to 85°C, stir for 20-25min to obtain the water phase mixture;

[0041] The water phase components include the following raw materials in parts by weight: 3 parts of glycerin, 1.2 parts of diphenhydramine hydrochloride, 55 parts of purified water;

[0042] Weigh the pharmaceutically active components and heat to 60°C, stir for 25 minutes to obtain the aqueous phase mixture; pharmaceutically active mixture;

[0043] The pharmaceutical active component comprises the...

Embodiment 3

[0047] A preparation method of a medicine for treating dermatitis, comprising the following steps:

[0048]1) Weigh the oil phase components and heat to 82°C, stir for 23 minutes to obtain the oil phase mixture;

[0049] The oil phase component includes the following raw materials in parts by weight: 3 kilograms of glyceryl monostearate, 3 kilograms of PEG-100 stearate, 3 kilograms of stearic acid, 1 kilogram of glycyrrhetinic acid, 3 kilograms of lanolin, 3 kg of shea butter;

[0050] Weigh the water phase components, heat to 82°C, and stir for 23 minutes to obtain the water phase mixture;

[0051] The water phase components include the following raw materials in kilograms by weight: 4 kilograms of glycerin, 1 kilogram of diphenhydramine hydrochloride, 55 kilograms of purified water;

[0052] Weigh the pharmaceutically active components and heat to 55°C, stir for 23 minutes to obtain the aqueous phase mixture; pharmaceutically active mixture;

[0053] The pharmaceutical ac...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to the technical field of medicines, in particular to a medicine for treating dermatitis and a preparation method thereof. The medicine for treating dermatitis is formed by blending following raw materials including, by weight, oil phase components comprising 2-6 parts of glyceryl monostearate, 2-6 parts of PEG-100 stearate, 2-5 parts of stearic acid, 0.5-1 part of glycyrrhetinic acid, 1-3 parts of lanolin and 2-4 parts of shea butter, aqueous phase components comprising 3-6 parts of glycerol, 0.8-1.2 parts of diphenhydramine hydrochloride and 55-60 parts of purified water, and pharmaceutical active components comprising 2-3 parts of chlorpheniramine maleate, 4-6 parts of propylene glycol, 1-2 parts of menthol, 1-2 parts of camphor and 0.1 part of tetracaine hydrochloride. The medicine has the beneficial effects that the main symptoms of dermatitis are itching, skin inflammation and elevated histamine level, and the components of the medicine are designed specific to the three symptoms of dermatitis correspondingly, so that the medicine has a coordinated effect on curing dermatitis.

Description

technical field [0001] The invention relates to the technical field of medicine, and relates to a medicine for treating dermatitis and a preparation method thereof. Background technique [0002] Dermatitis is an abbreviation for a skin inflammatory reaction. The factors causing dermatitis are complex and diverse. According to the cause, it can be divided into contact allergic dermatitis, neurodermatitis, bacterial dermatitis, sunburn dermatitis, drug-induced dermatitis, hormone-dependent dermatitis, etc. Wait. The main symptoms of dermatitis are erythema and rash, severe itching, and skin lesions in the epidermis and dermis of the skin. [0003] At present, the external medicines for dermatitis are mostly dermatitis hormones, supplemented by antibiotics, oral antihistamines combined with topical steroid hormones. However, topical steroid hormones will reduce the immune defense and cannot be used for long-term treatment because they can cause systemic disease. influences. ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K31/56A61K31/4402A61K31/135A61K31/245A61K47/44A61P17/00A61P37/08A61P17/04
CPCA61K31/56A61K31/135A61K31/245A61K31/4402A61K47/44A61K2300/00
Inventor 林维星
Owner 林维星
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap